Crooke细胞腺瘤与促肾上腺皮质激素腺瘤的内分泌结局比较:多中心国际分析结果
基于12个国际中心2017年1月至2020年12月手术治疗的垂体腺瘤患者,比较20例Crooke细胞腺瘤(CCA)与480例分泌性促肾上腺皮质激素腺瘤(sCTA)的结局。CCA的全切除率更高(100% vs 83%,P=0.05),但术后激素正常化(50% vs 77.8%,P<0.01)和3-6个月内分泌缓解率(75% vs 84.3%,P<0.01)均更低。
要点
- CCA全切除率100% vs sCTA 83%,P=0.05。
- 全切除者中CCA术后激素正常化50% vs sCTA 77.8%,P<0.01。
- CCA术后3-6个月内分泌缓解率75% vs sCTA 84.3%,P<0.01。
核心结论
- CCA患者预后较差,术后激素正常化率低于sCTA患者。
- 需进一步研究以理解CCA的病理生理并制定更靶向的治疗方法。
研究设计与样本
- 多中心国际回顾性数据库研究,纳入2017年1月至2020年12月手术治疗的垂体腺瘤患者。
- 共2826例来自12个国际中心,其中CCA 20例,sCTA 480例。
- 系统文献综述纳入35项报告不同治疗策略的研究。
主要发现
- 基线人口学、肿瘤特征及术后并发症在CCA与sCTA间无差异。
- 显微手术入路最常见(CCA 60% vs sCTA 62.3%)。
- CCA全切除率高于sCTA(100% vs 83%,P=0.05)。
- 术中全切除者中,CCA术后垂体功能激素正常化率低于sCTA(50% vs 77.8%,P<0.01),术后3-6个月内分泌缓解率也低于sCTA(75% vs 84.3%,P<0.01)。
- CCA局部控制率更高(100% vs 96%,P<0.01),MRI残留更少(0% vs 7.2%,P<0.01)。
关键数值与推荐
- CCA与sCTA全切除率:100% vs 83%,P=0.05。
- 全切除者术后激素正常化:CCA 50% vs sCTA 77.8%,P<0.01。
- 全切除者术后3-6个月内分泌缓解:CCA 75% vs sCTA 84.3%,P<0.01。
- 局部控制率:CCA 100% vs sCTA 96%,P<0.01。
- MRI残留:CCA 0% vs sCTA 7.2%,P<0.01。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Crooke cell adenomas (CCAs) are a rare, aggressive subset of secretory pituitary corticotroph adenomas (sCTAs) found in 5%-10% of patients with Cushing disease. Multiple studies support worse outcomes in CCAs but are limited by small sample size and single-institution databases. We compared outcomes in CCA and sCTA using a multicenter, international retrospective database of high-volume skull base centers. METHODS: Patients surgically treated for pituitary adenoma from January 2017 through December 2020 were included. RESULTS: Among 2826 patients from 12 international centers, 20 patients with CCA and 480 patients with sCTA were identified. No difference in baseline demographics, tumor characteristics, or postoperative complications was seen. Microsurgical approaches (60% CCA vs. 62.3% sCTA) were most common. Gross total resection was higher in CCA patients (100% vs. 83%, P = 0.05). Among patients with gross total resection according to intraoperative findings, fewer CCA patients had postoperative hormone normalization of pituitary function (50% vs. 77.8%, P < 0.01) and remission of hypersecretion by 3-6 months (75% vs. 84.3%, P < 0.01). This was the case despite CCA having better local control rates (100% vs. 96%, P < 0.01) and fewer patients with remnant on magnetic resonance imaging (0% vs. 7.2%, P < 0.01). A systematic literature review of 35 studies reporting on various treatment strategies reiterated the high rate of residual tumor, persistent hypercortisolism, and tumor-related mortality in CCA patients. CONCLUSIONS: This modern, multicenter series of patients with CCA reflects their poor prognosis and reduced postsurgical hormonal normalization. Further work is necessary to better understand the pathophysiology of CCA to devise more targeted treatment approaches.
引用
- Findlay MC, Drexler R, Azab M, et al. Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis. World Neurosurg. 2023. PMID: 37757948. doi:10.1016/j.wneu.2023.09.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。